You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0692 Effects of intravenous golimumab on patient-reported outcomes in active ankylosing spondylitis: 28-week results of the phase III go-alive trial

Alerts

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Spondyloarthritis - treatment
AB0692 Effects of intravenous golimumab on patient-reported outcomes in active ankylosing spondylitis: 28-week results of the phase III go-alive trial
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address